Lincoln Capital Corp’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,637
Closed -$228K 105
2026
Q1
$228K Sell
2,637
-19,956
-88% -$1.91M 0.08% 90
2025
Q4
$2.17M Buy
22,593
+76
+0.3% +$7.38K 0.77% 36
2025
Q3
$2.14M Sell
22,517
-4,265
-16% -$392K 0.77% 36
2025
Q2
$2.33M Sell
26,782
-308
-1% -$26.1K 0.9% 35
2025
Q1
$2.43M Buy
+27,090
New +$2.42M 1.01% 31
2020
Q4
Sell
-14,988
Closed -$1.56M 58
2020
Q3
$1.56M Sell
14,988
-1,705
-10% -$171K 1.14% 25
2020
Q2
$1.53M Buy
16,693
+1,563
+10% +$150K 1.2% 24
2020
Q1
$1.36K Buy
15,130
+3,055
+25% +$325K 0.61% 24
2019
Q4
$1.37M Buy
12,075
+7,207
+148% +$791K 1.02% 31
2019
Q3
$529K Buy
+4,868
New +$508K 0.45% 39

Other funds holding MDT

Lincoln Capital Corp's MDT Position: Q2 2026 in Review

Lincoln Capital Corp sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,637 shares — an estimated $228K sold.

Lincoln Capital Corp first reported a position in MDT in Q3 2019 and held it in 10 quarters. The position peaked at $2.43M in Q1 2025. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Lincoln Capital Corp reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Lincoln Capital Corp sold 2,637 Medtronic shares in Q2 2026, an estimated $228K.
  • Lincoln Capital Corp first reported a position in Medtronic in Q3 2019 and held it in 10 quarters.
  • Lincoln Capital Corp's Medtronic position peaked at $2.43M in Q1 2025.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Lincoln Capital Corp's 13F filing for Q2 2026, filed 16 Jul 2026.